PrediSurge announces collaboration with Medtronic, empowering physicians with software to assess risk and help understand complications

Nov 19, 2024 | Press

PlanOp ERI

St-Etienne, 19/11/2024

PrediSurge announces a collaboration with Medtronic to bring PrediSurge to customers who have chosen to use Medtronic’s industry leading EndurantTM stent graft for their patients. The patient-specific PrediSurge technology uses cutting-edge artificial intelligence and digital twin technologies, designed to bring endovascular aortic care to a new level through personalized predictive simulations. These simulations are used for aortic stent graft interventions to accurately assess the risk of endoleaks, aiming to enable precise planning of stent graft deployment. The PrediSurge technology, when simulating the potential use of Medtronic’s Endurant stent graft, results in a new service called SmartPlan Pro, designed to provide enhanced planning accuracy and reliability.

 

 

After 15 years of research and evidence-driven scientific development, PrediSurge has developed a unique AI-powered digital twin technology, designed to evaluate complication risks preoperatively. PrediSurge’s technology, in conjunction with Medtronic’s Endurant stent graft, powers the SmartPlan Pro service, leveraging the strength of both parties to enhance aortic procedure planning. This service combines the software developed by PrediSurge and the hardware and sizing & planning expertise from Medtronic, aiming to support the choice of intervention strategy by providing patient-centric quantitative analysis, such as a risk of endoleaks.

The digital twin technology developed by PrediSurge enables the creation of patient- specific virtual deployments of the stent graft. Simulation of different intervention scenarios enables physicians to assess complication risks and supports the selection of the best strategy for a given patient.

This collaboration will enable Medtronic to expand its portfolio of digital solutions and PrediSurge to continue its expansion and offer its software across Europe.

 

 

About PrediSurge

Founded in May 2017 in Saint-Étienne (France), PrediSurge is a spin-off company from the biomechanical laboratory of Mines Saint-Étienne. PrediSurge develops predictive software solutions that assists physicians and Medtech companies in better planning endovascular interventions. Based on pre-operative imaging, its technology enables creation of patient- specific digital twins: a near perfect virtual copy of the aorta that mimics its behavior and defining characteristics to assess complications risks prior to the surgery.

 

Contact

Alessia Campanella – alessia.campanella@predisurge.com

Other news

PrediSurge at PVI

PrediSurge at PVI

We’re proud to be part of the Paris Vascular Insights Course, a gathering of the brightest minds in vascular care. We were focused on how PrediSurge’s digital twin technology is redefining precision in procedures like carotid artery stenting. Our team was there to...

lire plus
PrediSurge at VEITH symposium

PrediSurge at VEITH symposium

We are delighted to join the vascular community at this prestigious event, where we are showcasing how PrediSurge is advancing cardiovascular care through innovation and cutting-edge technology. Our team is engaging with clinicians and experts to explore new...

lire plus
PrediSurge at ESVS

PrediSurge at ESVS

  We are thrilled to share the highlights of our recent participation at the European Society for Vascular Surgery (ESVS) Annual Meeting 2024, held in Kraków. It was an incredible opportunity to engage with the cardiovascular community and showcase the latest...

lire plus